Cost of illness of tuberculosis in Penang, Malaysia

Pharmacy World and Science

Volumn 30, Issue 3, 2008, Pages 281-286

  Elamin, Elfatih Ibrahim ^a   Ibrahim, Mohamed Izham Mohamed ^a   Sulaiman, Syed Azhar Syed ^a   Muttalif, Abdul Razak ^b  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b Penang Adventist Hospital   (Malaysia)

Author keywords

Cost of illness; Direct cost; Government hospital setting; Indirect cost; Malaysia; Pharmacoeconomics; Tuberculosis (TB)

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DRUG COST; HOSPITALIZATION COST; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALAYSIA; PUBLIC HEALTH SERVICE; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; ETHNIC GROUPS; FEMALE; HUMANS; MALAYSIA; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; TUBERCULOSIS;

EID: 42249083231     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-007-9185-0     Document Type: Article

References (18)

1. World Health Organization. Anti-tuberculosis drug resistance in the world. Geneva: WHO Global TB Programme; 1997.
2. Elsony A, Suliaman E, Shinawy A. Manual of tuberculosis control programme in Sudan, 3rd ed. Sudan: Federal Ministry of Health; 2000.
3. American Thoracic Society. Diagnostic standard, classification of TB in adults and children. Am. J. Respir. Care Med. 2000;161:1376-95.
4. World Health Organization. Towards a TB free future. Geneva: WHO/CDS/STB; 2001.
5. The Caribbean Epidemiology Centre. Tuberculosis manual of prevention & control procedures 1st ed. Trinidad; 1997.
6. World Health Organization. The economic impacts of tuberculosis. Amsterdam: Stop TB Initiative; 2000.
7. Wyss K, Kilima P, Lorenz N. Cost of tuberculosis for household and health care providers in Dar es Salaam, Tanzania. Trop. Med. Int. Health 2001;6:60-8.
8. Iseman M, Chan E. Current medical treatment for tuberculosis. BMJ 2002;320:282-6.
9. Lyawoo K. Tuberculosis in Malaysia: problems and prospect of treatment and control. Tuberculosis 2004;84:4-7.
10. Malaysia Tuberculosis Control Programme. NTB report for the year 2001. Malaysia: Ministry of Health; 2001.
11. Zwarenstein M, Schoeman J, Vundule C, Lombard C, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of Tuberculosis. Lancet 1998;352:1340-1343.
12. Jerant A, Bannon M, Rittenhouse S. Identification and management of Tuberculosis. Am. Fam. Physician 2000;61:2667-2678.
13. Centers for Disease Control and Prevention. Core curriculum on tuberculosis, 4th ed. Atlanta: Department of Health & Human services; 2000.
14. Islam M, Wakai S, Ishikawa N, Chowdhury A, Vaughan J. Cost-effectiveness of community health workers in tuberculosis control in Bangladesh. Bull. World Health Organ. 2002;80:445-50.
15. Sanderson P. An economic evaluation of alternative programme designs for Tuberculosis control in rural Uganda. Soc. Sci. Med. 1995;40:1203-1212.
16. Hurtiga A, Pande S, Porter J, Dam D. Tuberculosis treatment and private practitioners in Kathmandu Valley. J. Nap. Med. Assoc. 2000;39:163-8.
17. Guwatudde D, Zalwango S, Kamy M, Debanne S, Diaz M, Okwera A, Mugerwa R, King C, Whalen C. Burden of tuberculosis in Kamala, Uganda. Bull. World Health Organ. 2003;81(11):799-805.
18. Centers for Disease Control and Prevention. morbidity and mortality weekly report-treatment of tuberculosis. June 20, 2003/52(RR11);1-77.